Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The rising price of insulin ... provide affordable insulin for everyone and that needs to change.” The company outlined that it would launch a nationwide campaign in the country to ensure ...

The reason for the sharp increase seems to be simple: corporate greed. Recently, though, the high price of insulin has gone too far. Government agencies at both the state and federal levels are ...

The lawsuits generally make two claims: that insulin prices are unreasonably high and that drug companies and PBMs are responsible. The lawsuits are on firmer ground in their claim that PBMs are ...

has guaranteed that Wyoming residents not enrolled in government healthcare programs can buy insulin products for $35 each month for the next five years. The settlement announced by Attorney ...

Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

In recent years, these companies have been questioned over the price of insulin in congressional hearings and investigations. In response to public pressure and changing market dynamics ...

However, she did vote for a $35 cap on insulin prices earlier the same year. The claim goes on to say she voted against the insulin cap ”on the same day she took money from an insulin ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...